Mendeleev Communications
RUS  ENG    JOURNALS   PEOPLE   ORGANISATIONS   CONFERENCES   SEMINARS   VIDEO LIBRARY   PACKAGE AMSBIB  
General information
Latest issue
Archive

Search papers
Search references

RSS
Latest issue
Current issues
Archive issues
What is RSS



Mendeleev Commun.:
Year:
Volume:
Issue:
Page:
Find






Personal entry:
Login:
Password:
Save password
Enter
Forgotten password?
Register


Mendeleev Communications, 2003, Volume 13, Issue 2, Pages 50–51
DOI: https://doi.org/10.1070/MC2003v013n02ABEH001750
(Mi mendc3951)
 

This article is cited in 19 scientific papers (total in 19 papers)

4,5-Dichloro-1,2-dithiole-3-thione in the synthesis of benzimidazole, benzoxazole and benzothiazole derivatives of 1,3-dithioles

V. A. Ogurtsova, O. A. Rakitina, Ch. W. Reesb, A. A. Smolentseva

a N.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Moscow, Russian Federation
b Department of Chemistry, Imperial College London, London, UK
Abstract: 4,5-Dichloro-1,2-dithiole-3-thione 2 undergoes a 1,3-dipolar cycloaddition with DMAD to give stable aliphatic thioacyl chloride 3, which is highly reactive towards nucleophiles such as o-substituted amines to give benzimidazole, benzoxazole and benzothiazole derivatives of 1,3-dithioles 9.
Bibliographic databases:
Document Type: Article
Language: English


Citation: V. A. Ogurtsov, O. A. Rakitin, Ch. W. Rees, A. A. Smolentsev, “4,5-Dichloro-1,2-dithiole-3-thione in the synthesis of benzimidazole, benzoxazole and benzothiazole derivatives of 1,3-dithioles”, Mendeleev Commun., 13:2 (2003), 50–51
Linking options:
  • https://www.mathnet.ru/eng/mendc3951
  • https://www.mathnet.ru/eng/mendc/v13/i2/p50
  • This publication is cited in the following 19 articles:
    Citing articles in Google Scholar: Russian citations, English citations
    Related articles in Google Scholar: Russian articles, English articles
    Mendeleev Communications
     
      Contact us:
     Terms of Use  Registration to the website  Logotypes © Steklov Mathematical Institute RAS, 2025